Merck in talks to acquire Cubist for over $8 bn: Sources
December 05, 2014 at 23:51 PM EST
Drug giant Merck is in talks to acquire antibiotics-maker Cubist for about $102 a share in cash, according to people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.